Boditech Med Inc. (KOSDAQ:206640)
14,710
+180 (1.24%)
Sep 19, 2025, 3:30 PM KST
Boditech Med Revenue
Boditech Med had revenue of 41.48B KRW in the quarter ending June 30, 2025, with 14.44% growth. This brings the company's revenue in the last twelve months to 149.40B, up 7.38% year-over-year. In the year 2024, Boditech Med had annual revenue of 138.16B with 2.94% growth.
Revenue (ttm)
149.40B
Revenue Growth
+7.38%
P/S Ratio
2.14
Revenue / Employee
276.15M
Employees
541
Market Cap
320.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 138.16B | 3.94B | 2.94% |
Dec 31, 2023 | 134.22B | 16.14B | 13.67% |
Dec 31, 2022 | 118.08B | -39.63B | -25.13% |
Dec 31, 2021 | 157.71B | 13.58B | 9.42% |
Dec 31, 2020 | 144.13B | 71.33B | 97.99% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
ABL Bio | 94.93B |